Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use

ConclusionsAmong seniors initiating oral bisphosphonates, we found that 60% receive at least 3  years of therapy when using an extended follow-up. Studies are needed to examine the benefits and harms of continuing bisphosphonate therapy beyond 3 years.

Source: Osteoporosis International - January 7, 2021 Category: Orthopaedics Source Type: research